Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(54 sites)
United States
Clinical Study Site, Goodyear, Arizona Clinical Study Site, Beverly Hills, California Clinical Study Site, Cerritos, California Clinical Study Site, Corona, California Clinical Study Site, Duarte, California Clinical Study Site, Huntington Beach, California Clinical Study Site, Irvine, California Clinical Study Site, Irvine, California Clinical Study Site, Los Angeles, California Clinical Study Site, Los Angeles, California Clinical Study Site, Murrieta, California Clinical Study Site, Orange, California Clinical Study Site, Pasadena, California Clinical Study Site, Torrance, California Clinical Study Site, Upland, California Clinical Study Site, West Hollywood, California Clinical Study Site, New Haven, Connecticut Clinical Study Site, Norwich, Connecticut Clinical Study Site, Hialeah, Florida Clinical Study Site, Orlando, Florida Clinical Study Site, Port Saint Lucie, Florida Clinical Study Site, Newnan, Georgia Clinical Study Site, Chicago, Illinois Clinical Study Site, Elmhurst, Illinois Clinical Study Site, O'Fallon, Illinois Clinical Study Site, Fort Wayne, Indiana Clinical Study Site, Edgewood, Kentucky Clinical Study Site, Saint Louis Park, Minnesota Clinical Study Site, Billings, Montana Clinical Study Site, Lincoln, Nebraska Clinical Study Site, New Brunswick, New Jersey Clinical Study Site, Mineola, New York Clinical Study Site, New York, New York Clinical Study Site, The Bronx, New York Clinical Study Site, Cincinnati, Ohio Clinical Study Site, Philadelphia, Pennsylvania Clinical Study Site, Philadelphia, Pennsylvania Clinical Study Site, Hermitage, Tennessee Clinical Study Site, Fort Worth, Texas Clinical Study Site, Salt Lake City, Utah Clinical Study Site, Charlottesville, Virginia Clinical Study Site, Spokane, Washington Clinical Study Site, Tacoma, Washington Clinical Study Site, Charleston, West Virginia Canada
Clinical Study Site, Montreal, Quebec Japan
Clinical Study Site, Aichi Clinical Study Site, Chiba Clinical Study Site, Fukuoka Clinical Study Site, Gifu Clinical Study Site, Hokkaido Clinical Study Site, Osaka Clinical Study Site, Tokyo Puerto Rico
Clinical Study Site, Rio Piedras United Kingdom
Clinical Study Site, London, England